Remove 2013 Remove Pharmaceutical products Remove Safety
article thumbnail

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

European Pharmaceutical Review

For at least a decade from 2013 until recently, LDL lowering treatments were stuck on a paradigm of just putting people on statins and not getting LDL levels down to certain goals” CETP inhibitors have been around for a while, but they have unfortunately been unsuccessful in getting onto the market commercially. “For

Pharma 97
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” The other side is the pipeline of new pharmaceutical products. About the authors.

article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region. Injection Safety Fact Sheet. 2011;29:7122–7124. Sharma D, Khamar S, Cullen A, et al. Innovative Drying Technologies for Biopharmaceuticals.